Regulation of Vascular and Renal Function by Metabolite Receptors

Annual Review of Physiology

Volumn 78, Issue , 2016, Pages 391-414

  Peti Peterdi, János ^a   Kishore, Bellamkonda K ^b   Pluznick, Jennifer L ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gut microbiota; Mitochondria; Nucleotides; SCFA; Short chain fatty acids; Vascularization

Indexed keywords

2 OXOGLUTARIC ACID; ADENOSINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; METABOLITE RECEPTOR; NUCLEIC ACID BASE; NUCLEOSIDE; NUCLEOTIDE; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; RECEPTOR; SHORT CHAIN FATTY ACID; SODIUM CHLORIDE; SUCCINIC ACID; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR;

ACID BASE BALANCE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL METABOLISM; CITRIC ACID CYCLE; FLUID BALANCE; HOMEOSTASIS; HUMAN; INTESTINE FLORA; KIDNEY FUNCTION; METABOLIC REGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WATER METABOLISM; ANIMAL; BLOOD VESSEL; KIDNEY; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD VESSELS; HOMEOSTASIS; HUMANS; KIDNEY; RECEPTORS, CELL SURFACE;

EID: 84958622179     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021115-105403     Document Type: Review

References (161)

1. Hebert SC. 2004. Physiology: orphan detectors of metabolism. Nature 429:143-45
2. Joyner MJ, Casey DP. 2014. Muscle blood flow, hypoxia, and hypoperfusion. J. Appl. Physiol. 1985 116:852-57
3. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. 2007. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282:4524-32
4. Leipziger J. 2003. Control of epithelial transport via luminal P2 receptors. Am. J. Physiol. Ren. Physiol. 284:F419-32
5. Tanaka S, Tanaka T, Nangaku M. 2014. Hypoxia as a key player in the AKI-to-CKD transition. Am. J. Physiol. Ren. Physiol. 307:F1187-95
6. Tokonami N, Morla L, Centeno G, Mordasini D, Ramakrishnan SK, et al. 2013. α-Ketoglutarate regulates acid-base balance through an intrarenal paracrine mechanism. J. Clin. Investig. 123:3166-71
7. Natarajan N, Pluznick JL. 2014. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am. J. Physiol. Cell Physiol. 307:C979-85
8. Cai TQ, Ren N, Jin L, Cheng K, Kash S, et al. 2008. Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochem. Biophys. Res. Commun. 377:987-91
9. Ahmed K, Tunaru S, Offermanns S. 2009. GPR109A, GPR109B and GPR81, a family of hydroxycarboxylic acid receptors. Trends Pharmacol. Sci. 30:557-62
10. Hara T, Kashihara D, Ichimura A, Kimura I, Tsujimoto G, Hirasawa A. 2014. Role of free fatty acid receptors in the regulation of energy metabolism. Biochim. Biophys. Acta 1841:1292-300
11. Papanicolaou KN, O'Rourke B, Foster DB. 2014. Metabolism leaves itsmark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria. Front. Physiol. 5:301
12. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, et al. 2004. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429:188-93
13. Regard JB, Sato IT, Coughlin SR. 2008. Anatomical profiling ofGprotein-coupled receptor expression. Cell 135:561-71
14. Correa PR, Kruglov EA, Thompson M, Leite MF, Dranoff JA, Nathanson MH. 2007. Succinate is a paracrine signal for liver damage. J. Hepatol. 47:262-69
15. Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, et al. 2009. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int. 76:1258-67
16. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, et al. 2008. Succinate receptorGPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J. Clin. Investig. 118:2526-34
17. Vargas SL, Toma I, Kang JJ, Meer EJ, Peti-Peterdi J. 2009. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J. Am. Soc. Nephrol. 20:1002-11
18. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, et al. 2008. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat. Med. 14:1067-76
19. Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, et al. 2008. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9:1261-69
20. Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, et al. 2009. The role of the GPR91 ligand succinate in hematopoiesis. J. Leukoc. Biol. 85:837-43
21. Banfi C, Ferrario S, De Vincenti O, Ceruti S, Fumagalli M, et al. 2005. P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction withTNFαand potential role in myocardial cell death. J. Mol. Cell. Cardiol. 39:929-39
22. Hamel D, Sanchez M, Duhamel F, Roy O, Honore JC, et al. 2014. G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery. Arterioscler. Thromb. Vasc. Biol. 34:285-93
23. Sundstrom L, Greasley PJ, Engberg S, Wallander M, Ryberg E. 2013. Succinate receptor GPR91, a Gαi coupled receptor that increases intracellular calcium concentrations through PLC β. FEBS Lett. 587:2399-404
24. Hu J, Li T, Du S, Chen Y, Wang S, et al. 2015. The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells. Int. J. Mol. Med. 36:130-38
25. Ariza AC,Deen PM, Robben JH. 2012. The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front. Endocrinol. 3:22
26. Deen PM, Robben JH. 2011. Succinate receptors in the kidney. J. Am. Soc. Nephrol. 22:1416-22
27. Favret S, Binet F, Lapalme E, Leboeuf D, Carbadillo J, et al. 2013. Deficiency in the metabolite receptor SUCNR1 (GPR91) leads to outer retinal lesions. Aging 5:427-44
28. Peti-Peterdi J. 2010. High glucose and renin release: the role of succinate and GPR91. Kidney Int. 78:1214-17
29. Goldberg ND, Passonneau JV, Lowry OH. 1966. Effects of changes in brain metabolism on the levels of citric acid cycle intermediates. J. Biol. Chem. 241:3997-4003
30. Krebs HA. 1970. Rate control of the tricarboxylic acid cycle. Adv. Enzyme Regul. 8:335-53
31. Fedotcheva NI, Sokolov AP, Kondrashova MN. 2006. Nonezymatic formation of succinate in mitochondria under oxidative stress. Free Radic. Biol. Med. 41:56-64
32. Sadagopan N, Li W, Roberds SL, Major T, Preston GM, et al. 2007. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am. J. Hypertens. 20:1209-15
33. SchurekHJ, Jost U, BaumgartlH, Bertram H, Heckmann U. 1990. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am. J. Physiol. Ren. Physiol. 259:F910-15
34. Peti-Peterdi J, Gevorgyan H, Lam L, Riquier-Brison A. 2013. Metabolic control of renin secretion. Pflüg. Arch. 465:53-58
35. Peti-Peterdi J, Harris RC. 2010. Macula densa sensing and signalingmechanisms of renin release. J. Am. Soc. Nephrol. 21:1093-96
36. Peti-Peterdi J, Kang JJ, Toma I. 2008. Activation of the renal renin-angiotensin system in diabetes-new concepts. Nephrol. Dial. Transplant. 23:3047-49
37. Hu J, Wu Q, Li T, Chen Y, Wang S. 2013. Inhibition of high glucose-induced VEGF release in retinal ganglion cells by RNA interference targeting G protein-coupled receptor 91. Exp. Eye Res. 109:31-39
38. Gnana-Prakasam JP, Ananth S, Prasad PD, Zhang M, Atherton SS, et al. 2011. Expression and irondependent regulation of succinate receptor GPR91 in retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 52:3751-58
39. Peti-Peterdi J. 2013. Mitochondrial TCA cycle intermediates regulate body fluid and acid-base balance. J. Clin. Investig. 123:2788-90
40. Schöneberg T, Hermsdorf T, Engemaier E, Engel K, Liebscher I, et al. 2007. Structural and functional evolution of the P2Y12-like receptor group. Purinergic Signal. 3:255-68
41. WittenbergerT, SchallerHC, Hellebrand S. 2001. An expressed sequence tag (EST) datamining strategy succeeding in the discovery of new G-protein coupled receptors. J. Mol. Biol. 307:799-813
42. Burnstock G. 2009. Purinergic signalling: past, present and future. Braz. J. Med. Biol. Res. 42:3-8
43. Burnstock G. 2012. Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. BioEssays 34:218-25
44. Alves LA, da Silva JH, FerreiraDN, Fidalgo-Neto AA, Teixeira PC, et al. 2014. Structural andmolecular modeling features of P2X receptors. Int. J. Mol. Sci. 15:4531-49
45. Harden TK, Sesma JI, Fricks IP, Lazarowski ER. 2010. Signalling and pharmacological properties of the P2Y receptor. Acta Physiol. 199:149-60
46. Jacobson KA, Balasubramanian R, Deflorian F, Gao ZG. 2012. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions. Purinergic Signal. 8:419-36
47. Surprenant A, North RA. 2009. Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71:333-59
48. Praetorius HA,Leipziger J. 2010. Intrarenal purinergic signaling in the control of renal tubular transport. Annu. Rev. Physiol. 72:377-93
49. Kishore BK, Ginns SM, Krane CM, Nielsen S, Knepper MA. 2000. Cellular localization of P2Y2 purinoceptor in rat renal inner medulla and lung. Am. J. Physiol. Ren. Physiol. 278:F43-51
50. Edwards RM. 2002. Basolateral, but not apical, ATP inhibits vasopressin action in rat inner medullary collecting duct. Eur. J. Pharmacol. 438:179-81
51. Kishore BK, Chou CL, Knepper MA. 1995. Extracellular nucleotide receptor inhibits AVP-stimulated water permeability in inner medullary collecting duct. Am. J. Physiol. Ren. Physiol. 269:F863-69
52. RouseD, Leite M, Suki WN. 1994. ATP inhibits the hydrosmotic effect of AVP in rabbit CCT: evidence for a nucleotide P2u receptor. Am. J. Physiol. Ren. Physiol. 267:F289-95
53. Mironova E, Boiko N, Bugaj V, Kucher V, Stockand JD. 2015. Regulation of Na+ excretion and arterial blood pressure by purinergic signalling intrinsic to the distal nephron: consequences and mechanisms. Acta Physiol. 213:213-21
54. Rieg T, Bundey RA, Chen Y, Deschenes G, Junger W, et al. 2007. Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. FASEB J. 21:3717-26
55. Stockand JD. 2010. Vasopressin regulation of renal sodium excretion. Kidney Int. 78:849-56
56. Kishore BK,Nelson RD, Miller RL, Carlson NG, Kohan DE. 2009. P2Y2 receptors and water transport in the kidney. Purinergic Signal. 5:491-99
57. Leipziger J. 2011. Luminal nucleotides are tonic inhibitors of renal tubular transport. Curr. Opin.Nephrol. Hypertens. 20:518-22
58. Toney GM, Vallon V, Stockand JD. 2012. Intrinsic control of sodium excretion in the distal nephron by inhibitory purinergic regulation of the epithelial Na+ channel. Curr. Opin. Nephrol. Hypertens. 21:52-60
59. Vallon V. 2008. P2 receptors in the regulation of renal transportmechanisms. Am. J. Physiol. Ren. Physiol. 294:F10-27
60. Vallon V, Rieg T. 2011. Regulation of renal NaCl and water transport by the ATP/UTP/P2Y2 receptor system. Am. J. Physiol. Ren. Physiol. 301:F463-75
61. ZhangY, Pop IL, CarlsonNG,Kishore BK. 2012. Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling. Am. J. Physiol. Ren. Physiol. 302:F70-77
62. ZhangY,LiL,Kohan DE, EcelbargerCM,Kishore BK. 2013. Attenuation of lithium-induced natriuresis and kaliuresis in P2Y2 receptor knockout mice. Am. J. Physiol. Ren. Physiol. 305:F407-16
63. Potthoff SA, Stegbauer J, Becker J,Wagenhaeuser PJ, Duvnjak B, et al. 2013. P2Y2 receptor deficiency aggravates chronic kidney disease progression. Front. Physiol. 4:234
64. Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, et al. 2015. P2Y12 receptor localizes in the renal collecting duct and its blockade augments arginine vasopressin action and alleviates nephrogenic diabetes insipidus. J. Am. Soc. Nephrol. In press
65. Kishore BK, CarlsonNG,EcelbargerCM, Kohan DE,MüllerCE, et al. 2015. Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. Acta Physiol. 214:176-88
66. Guan Z, Inscho EW. 2011. Role of adenosine 5-triphosphate in regulating renal microvascular function and in hypertension. Hypertension 58:333-40
67. Van Beusecum J, Inscho EW. 2015. Regulation of renal function and blood pressure control by P2 purinoceptors in the kidney. Curr. Opin. Pharmacol. 21:82-88
68. Hillman KA,Woolf AS, Johnson TM,Wade A, Unwin RJ,Winyard PJ. 2004. The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem. Biophys. Res. Commun. 322:434-39
69. Menzies RI, Unwin RJ, BaileyMA. 2015. Renal P2 receptors and hypertension. Acta Physiol. 213:232-41
70. Taylor SR, Turner CM, Elliott JI, McDaid J, Hewitt R, et al. 2009. P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20:1275-81
71. Arulkumaran N, Unwin RJ, Tam FW. 2011. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs 20:897-915
72. Booth JW, Tam FW, Unwin RJ. 2012. P2 purinoceptors: renal pathophysiology and therapeutic potential. Clin. Nephrol. 78:154-63
73. Guan Z, Osmond DA, Inscho EW. 2007. P2X receptors as regulators of the renal microvasculature. Trends Pharmacol. Sci. 28:646-52
74. Lu D, Insel PA. 2014. Cellular mechanisms of tissue fibrosis.6. Purinergic signaling and response in fibroblasts and tissue fibrosis. Am. J. Physiol. Cell Physiol. 306:C779-88
75. Nishiyama A, Rahman M, Inscho EW. 2004. Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Hypertens. Res. 27:791-804
76. Wildman SS, King BF. 2008. P2X receptors: epithelial ion channels and regulators of salt and water transport. Nephron Physiol. 108:60-67
77. Chen JF, Eltzschig HK, Fredholm BB. 2013. Adenosine receptors as drug targets-what are the challenges? Nat. Rev. Drug Discov. 12:265-86
78. Fredholm BB. 2010. Adenosine receptors as drug targets. Exp. Cell Res. 316:1284-88
79. SamselM,DzierzbickaK. 2011. Therapeutic potential of adenosine analogues and conjugates. Pharmacol. Rep. 63:601-17
80. Vallon V, Osswald H. 2009. Adenosine receptors and the kidney. Handb. Exp. Pharmacol. 193:443-70
81. Vallon V. 2003. Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol. Sci. 18:169-74
82. Laubach VE, French BA, Okusa MD. 2011. Targeting of adenosine receptors in ischemia-reperfusion injury. Expert Opin. Ther. Targets 15:103-18
83. Quezada C, Alarcon S, Jaramillo C, Munoz D, Oyarzun C, San Martin R. 2013. Targeting adenosine signaling to treatment of diabetic nephropathy. Curr. Drug Targets 14:490-96
84. Roberts V, Lu B, Rajakumar S, Cowan PJ, Dwyer KM. 2013. The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury. Purinergic Signal. 9:135-43
85. Yap SC, Lee HT. 2012. Adenosine and protection from acute kidney injury. Curr. Opin. Nephrol. Hypertens. 21:24-32
86. Hanner F, Lam L, Nguyen MT, Yu A, Peti-Peterdi J. 2012. Intrarenal localization of the plasma membrane ATP channel pannexin1. Am. J. Physiol. Ren. Physiol. 303:F1454-59
87. Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J. 2010. Connexins and the kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298:R1143-55
88. Lazarowski ER, Sesma JI, Seminario-Vidal L, Kreda SM. 2011. Molecular mechanisms of purine and pyrimidine nucleotide release. Adv. Pharmacol. 61:221-61
89. LohmanAW,Isakson BE. 2014. Differentiating connexin hemichannels and pannexin channels in cellular ATP release. FEBS Lett. 588:1379-88
90. Sipos A, Vargas SL, Toma I, Hanner F,WilleckeK, Peti-Peterdi J. 2009. Connexin 30 deficiency impairs renal tubular ATP release and pressure natriuresis. J. Am. Soc. Nephrol. 20:1724-32
91. Corriden R, Insel PA. 2010. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci. Signal. 3:re1
92. Kukulski F, Levesque SA, Sevigny J. 2011. Impact of ectoenzymes on p2 and p1 receptor signaling. Adv. Pharmacol. 61:263-99
93. Schetinger MR, Morsch VM, Bonan CD, Wyse AT. 2007. NTPDase and 5-nucleotidase activities in physiological and disease conditions: new perspectives for human health. BioFactors 31:77-98
94. Yegutkin GG. 2008. Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783:673-94
95. Zimmermann H, Zebisch M, Strater N. 2012. Cellular function and molecular structure of ectonucleotidases. Purinergic Signal. 8:437-502
96. Kishore BK, Isaac J, Fausther M, Tripp SR, Shi H, et al. 2005. Expression of NTPDase1 andNTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling. Am. J. Physiol. Ren. Physiol. 288:F1032-43
97. Vekaria RM, Shirley DG, Sevigny J, Unwin RJ. 2006. Immunolocalization of ectonucleotidases along the rat nephron. Am. J. Physiol. Ren. Physiol. 290:F550-60
98. Crikis S, Lu B, Murray-Segal LM, Selan C, Robson SC, et al. 2010. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.Am. J. Transplant. 10:2586-95
99. Lu B, Rajakumar SV, Robson SC, Lee EK, Crikis S, et al. 2008. The impact of purinergic signaling on renal ischemia-reperfusion injury. Transplantation 86:1707-12
100. OppermannM, Friedman DJ, Faulhaber-Walter R, Mizel D, Castrop H, et al. 2008. Tubuloglomerular feedback and renin secretion inNTPDase1/CD39-deficient mice. Am. J. Physiol. Ren. Physiol. 294:F965-70
101. KinseyGR, Huang L, Jaworska K, Khutsishvili K, Becker DA, et al. 2012. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J. Am. Soc. Nephrol. 23:1528-37
102. Wang YM, McRae JL, Robson SC, Cowan PJ, Zhang GY, et al. 2012. Regulatory T cells participate in CD39-mediated protection from renal injury. Eur. J. Immunol. 42:2441-51
103. Cheng D, Ren J, Jackson EK. 2010. Multidrug resistance protein 4 mediates cAMP efflux from rat preglomerular vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 37:205-7
104. Godecke A. 2008. cAMP: fuel for extracellular adenosine formation? Br. J. Pharmacol. 153:1087-89
105. Valiunas V. 2013. Cyclic nucleotide permeability through unopposed connexin hemichannels. Front. Pharmacol. 4:75
106. Jackson EK, Dubey RK. 2001. Role of the extracellular cAMP-adenosine pathway in renal physiology. Am. J. Physiol. Ren. Physiol. 281:F597-612
107. Bankir L, Ahloulay M, Devreotes PN, Parent CA. 2002. Extracellular cAMP inhibits proximal reabsorption: Are plasma membrane cAMP receptors involved? Am. J. Physiol. Ren. Physiol. 282:F376-92
108. Zhang W, Zhang Y, Wang W, Dai Y, Ning C, et al. 2013. Elevated ecto-5-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ. Res. 112:1466-78
109. Marlewski M, Smolenski RT, Szolkiewicz M, Aleksandrowicz Z, Rutkowski B, Swierczynski J. 2000. Increased rate of adenine incorporation into adenine nucleotide pool in erythrocytes of patients with chronic renal failure. Nephron 86:281-86
110. Bender E, Buist A, Jurzak M, Langlois X, Baggerman G, et al. 2002. Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. PNAS 99:8573-78
111. Kishore BK, Zhang Y, Gevorgyan H, Kohan DE, Schiedel AC, et al. 2013. Cellular localization of adenine receptors in the rat kidney and their functional significance in the inner medullary collecting duct. Am. J. Physiol. Ren. Physiol. 305:F1298-305
112. Thimm D, Schiedel AC, Peti-Peterdi J, Kishore BK, Muller CE. 2015. The nucleobase adenine as a signalling molecule in the kidney. Acta Physiol. 213:808-18
113. Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schillinger RM, et al. 2010. Bitter taste receptors on airway smoothmuscle bronchodilate by localized calcium signaling and reverse obstruction. Nat. Med. 16:1299-304
114. Griffin CA, Kafadar KA, Pavlath GK. 2009. MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Dev. Cell 17:649-61
115. Huang AL, Chen X, Hoon MA,Chandrashekar J, GuoW, et al. 2006. The cells and logic formammalian sour taste detection. Nature 442:934-38
116. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, et al. 2007. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. PNAS 104:15069-74
117. Kang N, Bahk YY, Lee N, Jae Y, Cho YH, et al. 2015. Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in α-cells of mouse pancreatic islets. Biochem. Biophys. Res. Commun. 460:616-21
118. Kim SH, Yoon YC, Lee AS, Kang N, Koo J, et al. 2015. Expression of human olfactory receptor 10J5 in heart aorta, coronary artery, and endothelial cells and its functional role in angiogenesis. Biochem. Biophys. Res. Commun. 460:404-8
119. Kimura I, Inoue D, MaedaT,HaraT, Ichimura A, et al. 2011. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). PNAS 108:8030-35
120. Margolskee RF, Dyer J, Kokrashvili Z, Salmon KS, Ilegems E, et al. 2007. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. PNAS 104:15075-80
121. ShahAS, Ben-ShaharY,MoningerTO, Kline JN, WelshMJ. 2009. Motile cilia of human airway epithelia are chemosensory. Science 325:1131-34
122. Spehr M, Gisselmann G, Poplawski A, Riffell JA, Wetzel CH, et al. 2003. Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 299:2054-58
123. Liu X, Gu F, Jiang L, Chen F, Li F. 2015. Expression of bitter taste receptor Tas2r105 in mouse kidney. Biochem. Biophys. Res. Commun. 458:733-38
124. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, et al. 2013. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. PNAS 110:4410-15
125. Pluznick JL, Zou DJ, Zhang X, Yan Q, Rodriguez-Gil DJ, et al. 2009. Functional expression of the olfactory signaling system in the kidney. PNAS 106:2059-64
126. Rajkumar P, Aisenberg WH, Acres OW, Protzko RJ, Pluznick JL. 2014. Identification and characterization of novel renal sensory receptors. PLOS ONE 9:e111053
127. Bugaut M. 1987. Occurrence, absorption and metabolism of short chain fatty acids in the digestive tract of mammals. Comp. Biochem. Physiol. B 86:439-72
128. Hill MJ, Drasar BS. 1975. The normal colonic bacterial flora. Gut 16:318-23
129. Le PE, Loison C, Struyf S, Springael JY, Lannoy V, et al. 2003. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278:25481-89
130. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, et al. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282-86
131. Samuel BS, Gordon JI. 2006. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. PNAS 103:10011-16
132. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, et al. 2014. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20:159-66
133. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, et al. 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. PNAS 105:16767-72
134. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457:480-84
135. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. 2003. The orphan G protein-coupled receptorsGPR41 andGPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312-19
136. TazoeH,Otomo Y, Karaki S, Kato I, Fukami Y, et al. 2009. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res. 30:149-56
137. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, et al. 2014. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40:128-39
138. Mortensen FV, Nielsen H, Mulvany MJ, Hessov I. 1990. Short chain fatty acids dilate isolated human colonic resistance arteries. Gut 31:1391-94
139. Nutting CW, Islam S, Daugirdas JT. 1991. Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am. J. Physiol. Heart Circ. Physiol. 261:H561-67
140. Nutting CW, Islam S, Ye MH, Batlle DC, Daugirdas JT. 1992. The vasorelaxant effects of acetate: role of adenosine, glycolysis, lyotropism, and pHi and Cai 2+. Kidney Int. 41:166-74
141. Keshaviah PR. 1982. The role of acetate in the etiology of symptomatic hypotension. Artif. Organs 6:378-87
142. Pagel MD, Ahmad S, Vizzo JE, Scribner BH. 1982. Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int. 21:513-18
143. Pluznick J. 2013. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes 5:202-7
144. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. 2014. The role of short-chain fatty acids in health and disease. Adv. Immunol. 121:91-119
145. Zaibi MS, Stocker CJ, O'Dowd J, Davies A, Bellahcene M, et al. 2010. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 584:2381-86
146. Bond JH,LevittMD.1976. Quantitative measurement of lactose absorption. Gastroenterology 70:1058-62
147. Demigne C, Remesy C. 1982. Influence of unrefined potato starch on cecal fermentations and volatile fatty acid absorption in rats. J. Nutr. 112:2227-34
148. Keys JE Jr,DeBarthe JV. 1974. Site and extent of carbohydrate, dry matter, energy and protein digestion and the rate of passage of grain diets in swine. J. Anim. Sci. 39:57-62
149. McNeil NI, Bingham S, Cole TJ, Grant AM, Cummings JH. 1982. Diet and health of people with an ileostomy.2. Ileostomy function and nutritional state. Br. J. Nutr. 47:407-15
150. Orskov ER, Fraser C, Mason VC, Mann SO. 1970. Influence of starch digestion in the large intestine of sheep on caecal fermentation, caecal microflora and faecal nitrogen excretion. Br. J. Nutr. 24:671-82
151. Perman JA, Modler S. 1983. Role of the intestinal microflora in disposition of nutrients in the gastrointestinal tract. J. Pediatr. Gastroenterol. Nutr. 2(Suppl. 1):193-96
152. Pomare EW, BranchWJ, Cummings JH. 1985. Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J. Clin. Investig. 75:1448-54
153. Saunders DR,Wiggins HS. 1981. Conservation of mannitol, lactulose, and raffinose by the human colon. Am. J. Physiol. Gastrointest. Liver Physiol. 241:G397-402
154. Wiggins HS. 1984. Nutritional value of sugars and related compounds undigested in the small gut. Proc. Nutr. Soc. 43:69-75
155. Van Orshoven NP, Jansen PA, Oudejans I, Schoon Y, Oey PL. 2010. Postprandial hypotension in clinical geriatric patients and healthy elderly: prevalence related to patient selection and diagnostic criteria. J. Aging Res. 2010:243752
156. Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. 2005. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J. Hypertens. 23:475-81
157. Khalesi S, Sun J, Buys N, Jayasinghe R. 2014. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64:897-903
158. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, et al. 2008. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453:396-400
159. Mell B, Jala VR,MathewAV, Byun J, Waghulde H, et al. 2015. Evidence for a link between gutmicrobiota and hypertension in the Dahl rat model. Physiol. Genomics 47:187-97
160. Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, et al. 2015. Gut dysbiosis is linked to hypertension. Hypertension 65:1331-40
161. Pluznick JL. 2013. Renal and cardiovascular sensory receptors and blood pressure regulation. Am. J. Physiol. Ren. Physiol. 305:F439-44